Would you consider localized therapies such as radiofrequency ablation to a lung metastasis or Yttrium-90 for liver metastases for disease control for ER+HER2- breast cancer patients with visceral oligometastatic disease who have progressed on all hormonally-targeted therapies and have chemotherapy as their next standard-of-care systemic treatment option?
Answer from: Medical Oncologist at Community Practice
If truly oligometastatic, then yes I would consider it. Would do a PET-CT plus bone scan to make sure no other site of disease beforehand.
Would consider duration of disease free survival before making a decision. If patient has been disease free for a long time, I would consider treatment of oligo...
Sign in or Register to read more